Abstract:Cytotoxic T lymphocytes (CTL) are a major factor in the control of HIV replication. CTL arise in acute infection, causing escape mutations to spread rapidly through the population of infected cells. As a result, the virus develops partial resistance to the immune response. The factors controlling the order of mutating epitope sites are currently unknown and would provide a valuable tool for predicting conserved epitopes. In this work, we adapt a well-established mathematical model of HIV evolution under dynamical selection pressure from multiple CTL clones to include partial impairment of CTL recognition, [Formula: see text], as well as cost to viral replication, [Formula: see text]. The process of escape is described in terms of the cost-benefit tradeoff of escape mutations and predicts a trajectory in the cost-benefit plane connecting sequentially escaped sites, which moves from high recognition loss/low fitness cost to low recognition loss/high fitness cost and has a larger slope for early escapes than for late escapes. The slope of the trajectory offers an interpretation of positive correlation between fitness costs and HLA binding impairment to HLA-A molecules and a protective subset of HLA-B molecules that was observed for clinically relevant escape mutations in the Pol gene. We estimate the value of [Formula: see text] from published experimental studies to be in the range (0.01-0.86) and show that the assumption of complete recognition loss ([Formula: see text]) leads to an overestimate of mutation cost. Our analysis offers a consistent interpretation of the commonly observed pattern of escape, in which several escape mutations are observed transiently in an epitope. This non-nested pattern is a combined effect of temporal changes in selection pressure and partial recognition loss. We conclude that partial recognition loss is as important as fitness loss for predicting the order of escapes and, ultimately, for predicting conserved epitopes that can be targeted by vaccines.

Human immunodeficiency virus (HIV) dynamics in secondary lymphoid tissues and the evolution of cytotoxic T lymphocyte (CTL) escape mutants

Intrapatient Evolutionary Dynamics in an Individual Infected with HIV-1 CRF01_AE Who Experienced Periods of Treatment Failure

Compartmental structure in the secondary lymphoid tissue can slow down in vivo HIV-1 evolution in the presence of strong CTL responses

Mathematical modeling of escape of HIV from cytotoxic T lymphocyte responses

HIV Infection Dynamics with Broadly Neutralizing Antibodies and CTL Immune Response

Hiv-1 Population Dynamics in Vivo: Implications for Pathogenesis, Effect of Cytokine and Therapy Strategy

[[Research Progress in Escape Mutations of the Human Immunodeficiency Virus under Pressure of HLA-Restricted Cytotoxic T Lymphocytes].

Evolution and transmission of stable CTL escape mutations in HIV infection

Advances in Cytotoxic T Cell Escape Mutations in HIV Infection

Constructing Lower-Bounds for CTL Escape Rates in Early HIV and SIV Infection

The Route of HIV Escape from Immune Response Targeting Multiple Sites Is Determined by the Cost-Benefit Tradeoff of Escape Mutations

A mathematical model for HIV dynamics with multiple infections: implications for immune escape

Modeling Within-Host Viral Dynamics: the Role of CTL Immune Responses in the Evolution of Drug Resistance

The effect of interference on the CD8+ T cell escape rates in HIV

Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy

Mild HIV-specific selective forces overlaying natural CD4+ T cell dynamics explain the clonality and decay dynamics of HIV reservoir cells

Follicular Regulatory CD8 T Cells Impair the Germinal Center Response in SIV and Ex Vivo HIV Infection

The effects of CTL immune response on HIV infection model with potent therapy, latently infected cells and cell-to-cell viral transmission

Hybrid Spreading Mechanisms and T Cell Activation Shape the Dynamics of HIV-1 Infection

Depletion and dysfunction of V|[ggr]|2V|[dgr]|2 T cells in HIV disease: mechanisms, impacts and therapeutic implications

Progress of HIV-specific CTL Responses among HIV-infected Individuals